138 related articles for article (PubMed ID: 3011461)
1. Antagonistic effects of bisoprolol on several beta-adrenoceptor-mediated actions in anaesthetized cats.
Schliep HJ; Schulze E; Harting J; Haeusler G
Eur J Pharmacol; 1986 Apr; 123(2):253-61. PubMed ID: 3011461
[TBL] [Abstract][Full Text] [Related]
2. Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs.
Schliep HJ; Harting J
J Cardiovasc Pharmacol; 1984; 6(6):1156-60. PubMed ID: 6084774
[TBL] [Abstract][Full Text] [Related]
3. The selectivity of beta-adrenoceptor antagonists on isoprenaline-induced changes in heart rate, blood pressure, soleus muscle contractility and airways function in anaesthetized cats.
Letts LG; Richardson DP; Temple DM; Williams LR
Br J Pharmacol; 1983 Oct; 80(2):323-34. PubMed ID: 6140058
[TBL] [Abstract][Full Text] [Related]
4. Beta-adrenoceptor blockade by atenolol, metoprolol and propranolol in the anaesthetized cat.
Lundgren B; Carlsson E; Herrmann I
Eur J Pharmacol; 1979 May; 55(3):263-8. PubMed ID: 37096
[TBL] [Abstract][Full Text] [Related]
5. Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots.
Wellstein A; Belz GG; Palm D
J Pharmacol Exp Ther; 1988 Jul; 246(1):328-37. PubMed ID: 2839668
[TBL] [Abstract][Full Text] [Related]
6. A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol.
Lipworth BJ; Irvine NA; McDevitt DG
Eur J Clin Pharmacol; 1991; 40(2):135-9. PubMed ID: 1676675
[TBL] [Abstract][Full Text] [Related]
7. An investigation into the type of beta-adrenoceptor mediating sympathetically activated renin release in the cat.
Johns EJ
Br J Pharmacol; 1981 Jul; 73(3):749-54. PubMed ID: 6113867
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the beta-adrenoreceptors which mediate the isoprenaline-induced changes in finger tremor and cardiovascular function in man.
Pringle TH; Riddell JG; Shanks RG
Eur J Clin Pharmacol; 1988; 35(5):507-14. PubMed ID: 2853055
[TBL] [Abstract][Full Text] [Related]
9. Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.
Chang PC; van Veen S; van der Krogt JA; Vermeij P; van Brummelen P
J Cardiovasc Pharmacol; 1988 Sep; 12(3):317-22. PubMed ID: 2464104
[TBL] [Abstract][Full Text] [Related]
10. Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy.
Wellstein A; Palm D; Belz GG; Butzer R; Polsak R; Pett B
Eur Heart J; 1987 Dec; 8 Suppl M():3-8. PubMed ID: 2897299
[TBL] [Abstract][Full Text] [Related]
11. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
Tattersfield AE; Cragg DJ; Bacon RJ
Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959
[TBL] [Abstract][Full Text] [Related]
12. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
Daul A; Hermes U; Schäfers RF; Wenzel R; von Birgelen C; Brodde OE
Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenoceptor selectivity of dobutamine: in vivo and in vitro studies.
Maccarrone C; Malta E; Raper C
J Cardiovasc Pharmacol; 1984; 6(1):132-41. PubMed ID: 6199596
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
Leopold G; Ungethüm W; Pabst J; Simane Z; Bühring KU; Wiemann H
Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic profile of the selective beta 1-adrenoceptor antagonist bisoprolol.
Harting J; Becker KH; Bergmann R; Bourgois R; Enenkel HJ; Fuchs A; Jonas R; Lettenbaur H; Minck KO; Schelling P
Arzneimittelforschung; 1986 Feb; 36(2):200-8. PubMed ID: 2870720
[TBL] [Abstract][Full Text] [Related]
16. Observations on the mechanism underlying the differences in exercise and isoprenaline tachycardia after cardioselective and non-selective beta-adrenoceptor antagonists.
McGibney D; Singleton W; Silke B; Taylor SH
Br J Clin Pharmacol; 1983 Jan; 15(1):15-9. PubMed ID: 6849739
[TBL] [Abstract][Full Text] [Related]
17. Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.
Perucca E; Pickles H; Richens A
Clin Pharmacol Ther; 1981 Apr; 29(4):425-33. PubMed ID: 6258838
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
Daemmgen JW; Engelhardt G; Pelzer H
Arzneimittelforschung; 1985; 35(1A):383-90. PubMed ID: 2859033
[TBL] [Abstract][Full Text] [Related]
19. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
Riddell JG; Shanks RG
Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
[TBL] [Abstract][Full Text] [Related]
20. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist.
Tesfamariam B; Allen GT
Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
